Targeted Peptide Therapy // IVUSE+

Folic Acid

Injectable Folic Acid bypasses GI absorption entirely, delivering 5mg/mL directly into muscle tissue to support rapid cellular division, red blood cell production, and optimal methylation.

5MG/ML

Red Blood Cell Formation Neural Protection DNA Synthesis Homocysteine Regulation

Clinician-prescribed. Ships from a licensed U.S. pharmacy.

The Mechanism

Why Injectable Beats Oral

Oral folic acid must survive stomach acid, get absorbed through the intestinal wall, then undergo enzymatic conversion by MTHFR into its active form (5-MTHF) before your body can use it. An estimated 50% of the population carries MTHFR gene variants (C677T or A1298C) that reduce this conversion by 30-70%. Add GI conditions, medications that interfere with absorption, and the rate-limited transport mechanism of the intestinal lining, and oral supplementation becomes unreliable at best. Injectable Folic Acid eliminates every one of those variables. Intramuscular delivery achieves 100% bioavailability, bypassing the gut entirely and flooding circulation with usable folate within hours. No conversion bottleneck. No absorption lottery. Serum levels rise predictably, dose after dose, giving your provider precise control over your folate status.

Clinical Data

The Evidence

100%

Bioavailability via intramuscular injection

50%

Of the population carries MTHFR variants affecting folate metabolism

82%

Of IVUSE+ patients reported noticeable improvements in sustained energy and cognitive clarity within the first 30 days of injectable Folic Acid protocol.

IVUSE+ patient survey data

Comparison

Oral Supplements vs. Injectable

Oral Supplements	Injectable
Absorption limited by GI tract health, stomach acid, and intestinal permeability	100% bioavailability, bypassing the GI tract entirely
Requires MTHFR enzymatic conversion, which is impaired in 50% of the population	No dependence on MTHFR enzyme activity for utilization
Serum levels rise slowly and plateau unpredictably over 8-12 weeks	Serum folate levels rise measurably within 24-48 hours of injection
Dosing is imprecise due to variable absorption rates between individuals	Precise dosing (5mg/mL) with predictable, repeatable pharmacokinetics
Often contains synthetic pteroylglutamic acid that competes with natural folate receptors	Clinical-grade formulation compounded by licensed 503A/503B pharmacy

Product Information

Details

Folic Acid (vitamin B9) is essential for DNA synthesis, methylation cycling, and red blood cell production. Your body cannot manufacture it. Every cell division in your body requires adequate folate to proceed correctly. Injectable Folic Acid delivers clinical-grade B9 directly into circulation, bypassing the gastrointestinal tract and the enzymatic conversion steps that limit oral supplementation. This is particularly critical for the estimated 50% of the population carrying MTHFR gene variants that impair folate metabolism.

Supports healthy red blood cell formation, reducing fatigue and improving oxygen delivery to tissues. Protects neural pathways by maintaining myelin sheath integrity and supporting neurotransmitter synthesis. Drives DNA synthesis and cellular repair, essential for tissue regeneration and immune function. Regulates homocysteine levels, a key biomarker linked to cardiovascular and cognitive health.

Administer Subcutaneously. Rotate injection sites between doses. Store refrigerated between 2-8°C. Allow to reach room temperature before injection.

Injection site soreness, redness, or mild swelling (resolves within 24-48 hours). Occasional mild nausea during the first 1-2 doses. Rare: allergic reaction (rash, itching, difficulty breathing). Discontinue and contact your provider immediately if this occurs.

Disclaimer and Transparency

Important Information About Compounded Injectables

Compounded medications are not reviewed or approved by the FDA and do not undergo the same pre-market evaluation as FDA-approved drugs.
IVUSE peptide injections are prepared using peptide ingredients by FDA-registered, U.S.-licensed 503A & 503B compounding pharmacies, where available and clinically appropriate.
Availability and formulation may vary based on state regulations, evolving clinical guidance, and pharmacy partners.

All prescriptions, treatment decisions, and care plans are made independently by licensed healthcare providers using their professional judgment. Images and product depictions are for illustration only; actual packaging and supplies may vary.

*If you are interested in a prescription product, IVUSE will coordinate a telehealth visit with a licensed medical provider who will determine whether you are an appropriate candidate based on your health profile and current standards of care. If approved, a prescription will be issued and filled by one of our partner pharmacies. All prescriptions are subject to provider discretion and clinical appropriateness.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. All information provided here is for educational purposes only and does not replace personalized medical advice from a qualified healthcare professional.

Stop the medication and contact your provider if you experience persistent or concerning symptoms. Seek immediate medical care if you develop signs of a severe allergic reaction (such as hives, facial swelling, or difficulty breathing) or any rapidly worsening symptom.